Brain-derived neurotrophic factor (BDNF) and its receptor TrkB are crucial for many forms of neuronal plasticity 1-6 , including structural long-term potentiation (sLTP) 7, 8 , which is a correlate of an animal's learning 7, [9][10][11][12] . However, it is unknown whether BDNF release and TrkB activation occur during sLTP, and if so, when and where. Here, using a fluorescence resonance energy transfer-based sensor for TrkB and two-photon fluorescence lifetime imaging microscopy [13][14][15][16] , we monitor TrkB activity in single dendritic spines of CA1 pyramidal neurons in cultured murine hippocampal slices. In response to sLTP induction 9,14-16 , we find fast (onset < 1 min) and sustained (>20 min) activation of TrkB in the stimulated spine that depends on NMDAR (N-methyl-d-aspartate receptor) and CaMKII signalling and on postsynaptically synthesized BDNF. We confirm the presence of postsynaptic BDNF using electron microscopy to localize endogenous BDNF to dendrites and spines of hippocampal CA1 pyramidal neurons. Consistent with these findings, we also show rapid, glutamate-uncaging-evoked, time-locked BDNF release from single dendritic spines using BDNF fused to superecliptic pHluorin [17][18][19] . We demonstrate that this postsynaptic BDNF-TrkB signalling pathway is necessary for both structural and functional LTP 20 . Together, these findings reveal a spine-autonomous, autocrine signalling mechanism involving NMDAR-CaMKIIdependent BDNF release from stimulated dendritic spines and subsequent TrkB activation on these same spines that is crucial for structural and functional plasticity.
, we monitor TrkB activity in single dendritic spines of CA1 pyramidal neurons in cultured murine hippocampal slices. In response to sLTP induction 9,14-16 , we find fast (onset < 1 min) and sustained (>20 min) activation of TrkB in the stimulated spine that depends on NMDAR (N-methyl-d-aspartate receptor) and CaMKII signalling and on postsynaptically synthesized BDNF. We confirm the presence of postsynaptic BDNF using electron microscopy to localize endogenous BDNF to dendrites and spines of hippocampal CA1 pyramidal neurons. Consistent with these findings, we also show rapid, glutamate-uncaging-evoked, time-locked BDNF release from single dendritic spines using BDNF fused to superecliptic pHluorin [17] [18] [19] . We demonstrate that this postsynaptic BDNF-TrkB signalling pathway is necessary for both structural and functional LTP 20 . Together, these findings reveal a spine-autonomous, autocrine signalling mechanism involving NMDAR-CaMKIIdependent BDNF release from stimulated dendritic spines and subsequent TrkB activation on these same spines that is crucial for structural and functional plasticity.
To address the role of BDNF-TrkB signalling in sLTP, we developed a fluorescence resonance energy transfer (FRET)-based sensor for TrkB consisting of two components: (1) TrkB fused to monomeric enhanced green fluorescent protein (TrkB-eGFP), and (2) an SH2 domain of the TrkB binding partner phospholipase Cγ1 (PLC-γ1) 21 fused to two copies of monomeric red fluorescent protein-1 (mRFP1-PLC-mRFP1; Fig. 1a and Supplementary Information). After TrkB activation via phosphorylation of Tyr816, the affinity of mRFP1-PLC-mRFP1 for TrkB-eGFP increases 21 , thereby allowing FRET to occur between the fluorophores (Supplementary Information). We validated the sensor in HeLa cells and cultured cortical neurons by showing it to be sensitive to BDNF, specific for Tyr816phosphorylation, and reversible when imaged by two-photon fluorescence lifetime imaging microscopy (2pFLIM) (Extended Data Fig. 1, Supplementary Information) . Furthermore, we demonstrated that the sensor could functionally replace endogenous TrkB in neurons of cultured hippocampal slices (Extended Data Fig. 2, Supplementary Information) .
Using this sensor, we biolistically transfected cultured rat hippocampal slices and imaged CA1 pyramidal neurons with 2pFLIM. In response to glutamate uncaging targeted to a single dendritic spine (30 pulses at 0.5 Hz), spine volume rapidly increased by ~220% (transient phase) before relaxing to an increased state of ~90% lasting at least 60 min (sustained phase; Fig. 1b , c, Extended Data Fig. 3a )-changes independent of protein synthesis (Extended Data Fig. 3c, d ) and largely consistent with previous descriptions of sLTP (Extended Data Fig. 3a , Supplementary Information) 9,14-16 . At the same time, TrkB rapidly activated in the stimulated spine, peaking at ~1-2 min and remaining elevated for at least 60 min (Fig. 1b, d , e, Extended Data Figs 3b, 4 and Supplementary Information). For the first 30-60 s after the onset of glutamate uncaging, this activation was largely restricted to the stimulated spine ( Fig. 1d-f , Supplementary Information). However, with time, TrkB activation in adjacent regions slowly increased, suggesting spreading of TrkB activation ( Fig. 1d-f ). The validity of the observed signal was confirmed by its dependence on kinase activity and Tyr816 phosphorylation and independence of sensor concentration and temperature (Extended Data Figs 5-7, Supplementary Information).
To explore mechanisms underlying this TrkB activation, we asked whether it required NMDAR-mediated Ca 2+ influx 7, 9, 15, 16 and subsequent CaMKII activation 9, 15 . Application of either the NMDAR inhibitor d-2-amino-5-phosphonovalerate (d-AP5; 100 μM) or the CaMKII inhibitor CN21 (ref. 22; 10 μM) impaired TrkB activation during the transient and sustained phases of sLTP while also inhibiting spine volume change ( Fig. 2a-d) , suggesting that TrkB is in part downstream of both NMDAR and CaMKII activation.
Next, we asked whether BDNF contributes to this TrkB activation. Using the extracellular BDNF scavenger TrkB-Ig (6-8 μg ml −1 ), we found impaired TrkB activation throughout sLTP with a similar impairment of spine volume change ( Fig. 2e-h ), suggesting a crucial role for BDNF in mediating glutamate-uncaging-induced TrkB activation. To examine the cellular source of BDNF underlying this activation, we sparsely transfected the sensor with Cre recombinase in slices from Bdnf fl/fl mice, thereby selectively knocking-out BDNF synthesized in the postsynaptic cell, a perturbation without detectable effect on basal spine morphology 23, 40, 41 (Extended Data Fig. 8a, b ). This manipulation attenuated glutamate-uncaging-evoked TrkB activation and sLTP ( Fig. 2i-l) while leaving CaMKII activation intact (Extended Data Fig. 8c-f ). These results implicate autocrine BDNF as one mechanism underlying TrkB activation during sLTP: additional mechanisms could include other sources of BDNF (pre-synaptic, paracrine) or nonneurotrophin TrkB activators (such as zinc) 24 . The dependence of glutamate-uncaging-induced TrkB activation on postsynaptically synthesized BDNF controversially suggests the existence of BDNF in dendrites or spines 25 . To provide more direct evidence, we used electron microscopy to examine BDNF localization in a previously characterized mouse line in which a C-terminal haemagglutinin (HA) epitope tag was added to the Bdnf coding sequence (Bdnf-HA) 26 . Using highly sensitive antibodies against the HA-tag, we found BDNF not only in axons but also in dendrites and spines of CA1 pyramidal cells of these mice (Fig. 3) .
The localization of BDNF to dendritic spines, together with the rapid kinetics and initial spine restriction of glutamate-uncaginginduced TrkB activation, suggested an equally rapid release of BDNF from dendritic spines during the transient phase of sLTP. To assess this possibility, we used biolistics to transfect CA1 pyramidal cells with full-length BDNF containing the pH-sensitive fluorophore superecliptic pHluorin (SEP) fused to its C terminus, thus allowing visualization of exocytosed Supplementary Information). In response to glutamate uncaging, we observed an increase in SEP fluorescence largely restricted to the stimulated spine (Fig. 4a, b , Supplementary Video 1), with two distinct kinetic profiles. The first was a transient, spike-like increase time-locked to each uncaging pulse (Fig. 4a-c ), perhaps correlating with activity-induced BDNF release. The second was a slow increase in fluorescence commencing with the start of uncaging and peaking at its end, perhaps due to extracellular accumulation of released BDNF-SEP (Fig. 4a, b) . After termination of uncaging, SEP fluorescence decayed back to baseline over the course of 10 min (Extended Data Fig. 9e ).
Several lines of evidence suggested that these transient, spike-like increases in SEP fluorescence were in fact due to BDNF release from the spine. First, the observed fluorescence signal depended on pH, exocytosis, and BDNF sorting machinery 27 (Fig. 4c, d , Extended Data  Fig. 9d, Supplementary Information) . Second, expression of BDNF-SEP rescued structural plasticity in the setting of postsynaptic BDNF knockout, thus suggesting that it could functionally replace endogenous BDNF in neurons (Fig. 4e, f, Supplementary Information) . Third, the observed BDNF-SEP signal was independent of the presence of endogenous postsynaptic BDNF (Fig. 4g, h) . Fourth, the kinetic profile of the signal paralleled the time course of TrkB activation, as one would expect for BDNF release (Extended Data Fig. 4) . Collectively, these results suggest that the observed increase in SEP signal probably reports glutamate-dependent exocytosis and release of BDNF from stimulated spines.
To explore mechanisms underlying glutamate-induced BDNF release, we inhibited NMDARs (with AP5) or AMPARs (with NBQX) individually and together as well as inhibiting CaMKII with CN21 ( Fig. 4c, d) . We found the SEP signal to be largely blocked (AP5), unaffected (NBQX), completely blocked (AP5 plus NBQX), and partially blocked (CN21) by these perturbations (Fig. 4c, d ). These findings suggest that BDNF release from spines is largely NMDAR-CaMKII dependent, consistent with our results for TrkB activation.
The converging evidence implicating autocrine BDNF-TrkB signalling in sLTP led us to ask whether this pathway was also involved ) impaired both sLTP (in cultured slices) and fLTP (in acute slices) (Extended Data Fig. 10a-d) , implicating BDNF as one mechanism underlying TrkB activation in this context.
To determine whether autocrine BDNF-TrkB signalling in particular contributed to these forms of plasticity, we knocked out BDNF in a small population of CA1 pyramidal cells using either in utero infection of adeno-associated virus encoding synapsin-Cre in Bdnf fl/fl mice for fLTP in acute slices or biolistic transfection of Cre in organotypic slices prepared from Bdnf fl/fl mice for sLTP. The knockout of postsynaptic BDNF impaired both fLTP and sLTP, the latter of which was rescued by bath-applied BDNF (20 ng ml −1 for 10 min) ( Fig. 5e-h ). Collectively, these results reveal a requirement of a cell-autonomous, postsynaptic BDNF release and subsequent activation of postsynaptic TrkB for both structural and functional synaptic plasticity (Extended Data Fig. 10e , Supplementary Information). Overall, we have described an autocrine signalling system within a single spine achieved by rapid BDNF release from the stimulated spine and subsequent TrkB activation on the same spine that, potentially in cooperation with other sources of BDNF and activators of TrkB, is essential for both structural and functional plasticity.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. 
Letter reSeArCH

MethOdS
Reagents. Human recombinant BDNF and human recombinant β-NGF were purchased from Millipore, K252a and d-2-amino-5-phosphonovalerate (d-AP5) and 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione (NBQX) were from Tocris, human-IgG was from Sigma, and 1'-naphthylmethyl-4-amino-1-tert-butyl-3-(p-methylphenyl)pyrazolo [3,4-d] pyrimidine (1NMPP1) was from Santa Cruz and Shanghai Institute of Materia Medica, Chinese Academy of Sciences. TrkB-Ig was a gift from Regeneron and the tat-CN21 peptide (YGRKKRRQRRRKRPPKLGQIGRSKRVVIEDDR) was synthesized by GenScript. Plasmids. TrkB-eGFP was prepared by inserting the coding sequence of mouse TrkB (obtained from a previously described plasmid 29 ) into pEGFP-N1 (Clontech) containing the A206K monomeric mutation in eGFP and the CAG promoter 30 . The linker between TrkB and eGFP is TGRH. mRFP1-PLC-mRFP1 was prepared by inserting the coding sequence for the C-terminal SH2 domain of human PLC-γ1 (659-769; obtained from full-length, human PLC-γ1 purchased from Origene) into a tandem-mRFP1 plasmid containing the CAG promoter. The linkers between the mRFP1s and PLC-γ1 (659-769) are RSRAQASNS for the N terminus and GSG for the C terminus. TrkB Y816F -eGFP was prepared by introducing a point mutation using the Site-Directed Mutagenesis Kit (Stratagene). Tandem mCherry (mCh-mCh) was generated as previously described , and Bdnf-HA mice were generated as previously described 26 . The genotype of each animal used was verified before and after preparing slices using PCR of genomic DNA isolated from tail DNA before and slice samples after. Preparation of HeLa cells. HeLa cells were obtained from the Duke University Cell Culture Facility. These cells had been authenticated using short-tandem repeat profiling and evaluated for mycoplasma contamination. Cells were cultured and maintained as previously described 16 . Cells were transfected with Lipofectamine 2000 using the manufacturer's protocol (Invitrogen). Concentrations used were 0.5 μl ml −1 Lipofectamine and 1 μg ml −1 total cDNA (1:1 ratio of TrkB-eGFP to mRFP1-PLC-mRFP1 DNA). Then, 24-48 h later, culture media was replaced with HEPES-buffered ACSF for imaging (HACSF; 20 mM HEPES, 130 mM NaCl, 2 mM NaHCO 3 , 25 mM d-glucose, 2.5 mM KCl and 1.25 mM NaH 2 PO 4 ; adjusted to pH 7.4 and 310 mOsm). After a 30-min equilibration period, transfected cells were imaged using 2pFLIM as described below. Cell stimulation was performed by directly adding BDNF or vehicle to the HACSF bathing the cells. Preparation of mixed cortical cultures. Mixed cortical cultures were prepared as described previously 33 and transfected with Lipofectamine 2000 using a modified protocol. For transfection of neurons in 3.5 cm dishes, 1 μl Lipofectamine was mixed with 1 μg of plasmid DNA (1 μg per construct transfected) in 100 μl of culture media for 20 min. Culture media was removed from the 3.5 cm dish until only 1 ml remained. The Lipofectamine/DNA solution was added to the neurons for 45 min. At this point, all the media was removed and replaced with 2 ml conditioned culture media. After 24-48 h, culture media was replaced with HACSF. To stimulate cells, we added BDNF or NGF directly to the HACSF bathing the cells. 30 min after stimulation, we added K252a to the HACSF. Preparation of organotypic hippocampal slices. Cultured hippocampal slices were prepared from post-natal day 5-7 rats or mice, as previously described 34 , in accordance with the animal care and use guidelines of Duke University Medical Center. After 5-12 days in culture, CA1 pyramidal neurons were transfected with biolistic gene transfer using gold beads (12 mg; Biorad) coated with plasmids containing 20-40 μg of total cDNA (TrkB sensor: 15 μg TrkB-eGFP and 15 μg mRFP1-PLC-mRFP1; TrkB sensor plus mCh: 5 μg TrkB-eGFP, 5 μg mRFP1-PLCmRFP1, and 20 μg mCh-mCh; TrkB sensor plus mCh and Cre: 5 μg TrkB-GFP, 5 μg mRFP1-PLC-mRFP1, 5 μg tdTom-Cre, and 15 μg mCh-mCh; BDNF-SEP plus mCh: 20 μg BDNF-SEP and 10 μg mCh-mCh; BDNF-SEP plus TeTX: 20 μg BDNF-SEP and 10 μg mCh-IRES-TeTX; BDNF-SEP plus POMC: 20 μg BDNF-SEP and 10 μg POMC-mCh; eGFP: 20 μg eGFP; and eGFP plus Cre: 10 μg eGFP plus 10 μg tdTom-Cre). Neurons expressing the TrkB sensor were imaged 12-48 h after transfection. Neurons expressing the TrkB sensor with mCh or mCh plus Cre were imaged 5-7 days after transfection. The addition of the mCh proved critical in limiting the TrkB sensor expression thereby allowing neurons to survive longer with the sensor present. Neurons expressing only eGFP were imaged 1-7 days after transfection. Neurons expressing eGFP plus Cre were imaged 5-9 days after transfection. 2pFLIM. FRET imaging using a custom-built two-photon fluorescence lifetime imaging microscope was performed as previously described 13, 35 . Two-photon imaging was performed using a Ti-sapphire laser (MaiTai, Spectraphysics) tuned to a wavelength of 920 nm, allowing simultaneous excitation of eGFP, mRFP1 and mCh. All samples were imaged using <2 mW laser power measured at the objective. Fluorescence emission was collected using an immersion objective (60×, numerical aperture 0.9, Olympus), divided with a dichroic mirror (565 nm), and detected with two separate photoelectron multiplier tubes (PMTs) placed downstream of two wavelength filters (Chroma, HQ510-2p to select for green and HQ620/90-2p to select for red). The green channel was fitted with a PMT having a low transfer time spread (H7422-40p; Hamamatsu) to allow for fluorescence lifetime imaging, while the red channel was fitted with a wide-aperture PMT (R3896; Hamamatsu). Photon counting for fluorescence lifetime imaging was performed using a time-correlated single photon counting board (SPC-150; Becker and Hickl) controlled with custom software 13 , while the red channel signal was acquired using a separate data acquisition board (PCI-6110) controlled with Scanimage software 36 . Two-photon glutamate uncaging. A second Ti-sapphire laser tuned at a wavelength of 720 nm was used to uncage 4-methoxy-7-nitroindolinyl-caged-lglutamate (MNI-caged glutamate) in extracellular solution with a train of 4-6 ms, 4-5 mW pulses (30 times at 0.5 Hz) near a spine of interest. Experiments were performed in Mg 2+ free artificial cerebral spinal fluid (ACSF; 127 mM NaCl, 2.5 mM KCl, 4 mM CaCl 2 , 25 mM NaHCO 3 , 1.25 mM NaH 2 PO 4 and 25 mM glucose) containing 1 μM tetrodotoxin (TTX) and 4 mM MNI-caged l-glutamate aerated with 95% O 2 and 5% CO 2. Experiments were performed at 24-26 °C (room temperature) or 30-32 °C using a heating block holding the ACSF container. Temperature measurements were made from ACSF within the perfusion chamber holding the slice. 2pFLIM data analyses. To measure the fraction of donor bound to acceptor, we fit a fluorescence lifetime curve summing all pixels over a whole image with a double exponential function convolved with the Gaussian pulse response function:
in which τ AD is the fluorescence lifetime of donor bound with acceptor, P D and P AD are the fraction of free donor and donor bound with acceptor, respectively, and H(t) is a fluorescence lifetime curve with a single exponential function convolved with the Gaussian pulse response function:
in which τ D is the fluorescence lifetime of the free donor, τ G is the width of the Guassian pulse response function, F 0 is the peak fluorescence before convolution and t 0 is the time offset, and erfc is the error function. We fixed τ D to the fluorescence lifetime obtained from free mEGFP (2.6 ns). To generate the fluorescence lifetime image, we calculated the mean photon arrival time, 〈t〉, in each pixel as:
then, the mean photon arrival time is related to the mean fluorescence lifetime, 〈τ〉, by an offset arrival time, t 0 , which is obtained by fitting the whole image:
For small regions-of-interest (ROIs) in an image (spines or dendrites), we calculated the binding fraction (P AD ) as:
BDNF-SEP and BDNF-mRFP1 imaging. BDNF-SEP imaging was performed by interleaving 8 Hz two-photon imaging with two-photon glutamate uncaging (30 pulses at 0.5 Hz). Multiple (1-30) spines were imaged on each neuron. Change in BDNF-SEP fluorescence was measured as ΔF/F 0 after subtracting background fluorescence. Uncaging-triggered averages were calculated as the average increase in SEP fluorescence after each individual uncaging pulse. Red fluorescence increase was smoothed using a 16-frame window.
For visualizing BDNF-mRFP1 localization in CA1 pyramidal neurons, images were obtained using a Leica SP5 laser scanning confocal microscope (Leica). Spine volume analysis. During 2pFLIM and BDNF-SEP imaging (Figs 2, 3) , spine volume was reported using the red fluorescent intensity from mRFP1 or mCh. For two-photon imaging without FLIM (Fig. 4) , green fluorescent intensity from eGFP was used. In all experiments, spine volume was measured as the integrated fluorescent intensity after subtracting background (F). Spine volume change was calculated by F/F 0 , in which F 0 is the average spine volume before stimulation. Additionally, to compare basal spine size/morphology between various conditions, maximal spine (F max(spine) ) and dendrite (F max(dendrite) ) fluorescent intensities were measured and the F max(spine) /F max(dendrite) ratio was calculated after subtracting background fluorescence. In utero viral injection for single-cell BDNF knockout. E14.5/15.5 timed-pregnant Bdnf fl/fl mice were deeply anaesthetized using an isoflurane-oxygen mixture. The uterine horns were exposed and approximately 1-2 μl of AAV solution mix (containing AAV1.CAG.EGFP, AAV1.CAG.Flex.tdTomato and AAV1.hSyn.Cre, all from U Penn vector core) was injected through a pulled-glass capillary tube into the right lateral ventricle of each embryo. To achieve sufficient labelling of eGFP CA1 neurons alongside sparse expression of Cre + BDNF knockout tdTomato neurons, eGFP and Flex-tdTomato viruses were used at concentration of ~10 12 viral genome copies per μl, and Cre was diluted (~100-fold) in PBS at a dilution determined to achieve a sparse labelling density of Cre-positive CA1 neurons. Functional LTP. LTP experiments in Fig. 5 and Extended Data Fig. 10 Electrophysiological recordings were performed in ACSF (plus picrotoxin at MPFI). CA1 pyramidal neurons in acute hippocampal slices from wild-type and Trkb F616A mice were visualized using oblique illumination or differential interference contrast (DIC). For Bdnf fl/fl experiments, Cre-negative (eGFP-expressing) and Cre-positive (tdTomato-expressing) neurons were identified and targeted with fluorescence microscopy. Patch pipettes (3-6 MΩ) were filled with an internal solution (130 mM K gluconate, 10 mM, Na phosphocreatine 4 mM MgCl 2 ,4 mM NaATP, 0.3 mM MgGTP, 3 mM l-ascorbic acid and 10 mM HEPES, pH 7.4, and 310 mOsm at MPFI or K-gluconate 140 mM, HEPES 10 mM, EGTA 1 mM, NaCl 4 mM, Mg 2 ATP 4 mM, and Mg 2 GTP 0.3 mM, pH 7.25, and 290 mOsm at Duke). Series resistances (10-40 MΩ) and input resistances (100-300 MΩ) were monitored throughout the experiment using negative voltage steps. The membrane potential was held at −70 mV. Experiments were performed at room temperature (~21 °C) and slices were perfused with oxygenated ACSF. For Trkb F616A /wild-type experiments, 1NMMP1 or vehicle was added to the ACSF before stimulation. For TrkB-Ig experiments, slices were incubated in 2 μg ml −1 TrkB-Ig or control human IgG for at least 2 h before the experiments. EPSCs were evoked by extracellular stimulation of Schaffer collaterals using a concentric bipolar stimulating electrode (World Precision Instruments) at a rate of 0.03 Hz. LTP was induced by pairing a 2-Hz stimulation with a postsynaptic depolarization to 0 mV for 15 s (MPFI) or 75 s (Duke). EPSC potentiation was assessed for 30-45 min (for Trkb F616A experiments), 40-60 min (for Bdnf fl/fl experiments) or 20-30 min (for TrkB-Ig experiments) after stimulation. Immunoprecipitation. HeLa cells were transfected with the TrkB sensor (TrkBeGFP and mRFP1-PLC-mRFP1) using Lipofectamine 2000 as described above. Then, 24-48 h after transfection, the media bathing the cells was exchanged for HEPES buffered ACSF for biochemistry (150 mM NaCl, 3 mM KCl, 10 mM HEPES pH 7.35, 20 mM glucose, and 310 mOsM). After a 30-min equilibration period, cells were stimulated with 100 ng ml −1 BDNF for 10 min. Following stimulation, cells were washed in ice-cold PBS (Gibco), and then lysed in modified RIPA buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% NP-40, 0.25% sodium deoxycholate, 1 mM EDTA, 1 mM PMSF, 1 mM Na 3 VO 4 , and protease inhibitors) for 10 min on ice. The supernatant was collected after a 10 min centrifugation at 16,000g at 4 °C. At this point, a small volume of the supernatant was added to SDS-sample buffer and saved as the 'cell lysate' sample. The remaining supernatant was pre-cleared using protein G Sepharose beads (25 μl, Roche) for 30 min at 4 °C. After pre-clearing, the supernatant was incubated with 20 μg mouse monoclonal anti-phosphotyrosine (BD Transduction Labs) at 4 °C overnight. The immunocomplexes were precipitated with protein G Sepharose beads (50 μl) for 3 h at 4 °C and then analysed with western blotting. Antibodies used in western blotting included TrkB (Millipore), GFP (Abcam), actin (Sigma), and pTrkB(Y515) (Sigma).
Electron microscopic immunohistochemistry. Male adult (~2-3 months old)
Bdnf-HA knock-in mice 26 and aged matched wild-type C57/BL mice were used. The same investigator (T.A.M.) perfused all mice (Bdnf-HA and wild type) to maintain consistency between groups. Mice (3 per group) were deeply anaesthetized with sodium pentobarbital (150 mg kg −1 , i.p.) and perfused sequentially through the ascending aorta with: (1) ~5 ml saline (0.9%) containing 2% heparin, and (2) 30 ml of 3.75% acrolein and 2% paraformaldehyde in 0.1 M phosphate buffer (PB; pH 7.4) 38 . Following removal from the skull, the brain was post-fixed for in 2% acrolein and 2% paraformaldehyde in PB 30 min. Brains were then sectioned (40 μm thick) on a Vibratome and stored at −20 °C in cryoprotectant until use.
For each animal, two dorsal hippocampal sections were processed for immunoelectron microscopy (immunoEM) experiments using previously described methods 38 . Before immunohistochemical processing, sections were rinsed in PB, and experimental groups were coded with hole-punches so that tissue could be run in single crucibles, ensuring identical exposure to all reagents.
Before processing for immunolabelling, sections were treated with 1% sodium borohydride for 30 min to remove free aldehyde sites. Sections then were rinsed in PB followed by a rinse in 0.1 M Tris-saline (TS; pH 7.6) and then a 30 min incubation in 0.5% BSA in TS. Sections then were incubated in primary rabbit anti-HA (1:1,000; Sigma) in 0.025% Triton-X 100 and 0.1% BSA in TS for 1 day at room temperature and 4 days at 4 °C. Sections then were incubated in donkey anti-rabbit biotinylated IgG (1:400; Jackson Immunoresearch Laboratories) for 30 min followed by a 30 min incubation in avidin-biotin complex (ABC; Vectastain Elite Kit, Vector Laboratories) in TS (1:100 dilution). Sections were developed in 3,3′-diaminobenzidine (Sigma-Aldrich) and H 2 O 2 in TS. All antibody incubations were performed in 0.1% BSA/TS and separated by washes in TS.
Sections were post-fixed in 2% osmium tetroxide for 1 h, dehydrated, and flat embedded in Embed-812 (EMS) between two sheets of Aclar plastic. Brain sections containing the CA1 and dentate gyrus were selected from the plastic embedded sections, glued onto Epon blocks and trimmed to 1 mm-wide trapezoids. Ultra-thin sections (70 nm thickness) through the tissue-plastic interface were cut with a diamond knife (EMS) on a Leica EM UC6 ultratome, and sections were collected on 400-mesh, thin-bar copper grids (EMS). Grids were then counterstained with uranyl acetate and Reynold's lead citrate. Ultrastructural analysis. An investigator blinded to animal condition performed the data collection and analysis. One section from each of Bdnf-HA and wild-type animals was analysed (n = 3 each group). The thin sections were examined and photographed on a Tecnai Biotwin transmission electron microscope (FEI). Cell profiles were identified by defined morphological criteria 39 . Dendritic profiles generally were postsynaptic to axon terminals and contained regular microtubule arrays. Dendritic spines also were usually postsynaptic to axon terminal profiles and sometimes contained a spine apparatus. Axon terminals contained small synaptic vesicles and occasional dense-core vesicles. Unmyelinated axons were profiles smaller than 0.15 μm that contained a few small synaptic vesicles and lacked a synaptic junction in the plane of section. Glial profiles were distinguished by the presence of glial filaments (astrocytic profiles), by the presence of microtubules and/or their tendency to conform irregularly to the boundaries of surrounding profiles. 'Unknown profiles' were those that contained immunoperoxidase reaction product but could not be definitively placed in one of the above categories.
From each block, 4 grid squares (each square was 55 × 55 μm 2 ) each from the CA1 near stratum radiatum (nSR in Fig. 3 ; that is, adjacent to the pyramidal cell layer) and distal stratum radiatum (dSR in Fig. 3 ; that is, 50-150 μm away from the pyramidal cell layer) were randomly sampled for analysis. Thus, 12,100 μm 2 was sampled for each area in each block. Grid squares were selected plastic-tissue interface to ensure even antibody tissue penetration 38 . Immunoperoxidase labelling for HA was evident as a characteristic, electron-dense DAB reaction product precipitate. All peroxidase labelled profiles from each square were photographed and categorized. Animal codes were not broken until all 6 blocks were analysed. Statistical analysis. Sample sizes for all experiments were chosen based on signal-to-noise ratios identified in pilot experiments. Variances of all data sets were estimated and compared using Bartlett's or Levene's test before further statistical analysis. Randomization of animals and/or slices was not needed.
To evaluate distribution patterns of TrkB sensor activity, spine volume change, and BDNF-SEP signal, peak responses for each data set (the same points used for statistical comparisons) were subjected to a Shapiro-Wilk test for normality. TrkB sensor activity adhered to the null hypothesis (normal distribution) while spine volume change and BDNF-SEP signal did not.
Because TrkB sensor activity had a normal distribution, parametric statistics were used: paired and unpaired two-tailed t-test, ANOVA, and repeated-measures ANOVA with appropriate post-hoc analysis, as indicated in the figure legends and supplementary note. For t-tests, homoscedasticity between groups was evaluated Letter reSeArCH using the F-test. If variance was unequal, Welch's corrected t-test was performed. For ANOVA, homoscedasticity was evaluated with Bartlett's test. For multiple comparisons of sensor activity, data were subjected to ANOVA or repeated-measures ANOVA followed by a post-hoc test to determine statistical significance. In cases where each condition was compared to all other conditions in the experiment, the Tukey-Kramer method was employed. In cases where each condition was compared to a single control, Dunnet's test was used.
Since spine volume change had a non-normal distribution, data were log-transformed to resolve skewness and then analysed with parametric statistics (the same tests described above), as indicated in the figure legends.
For the BDNF-SEP signal, log-transformation of the data did not resolve the skewness. As such, non-parametric statistics were used-Wilcoxon rank-sum test and Kruskal-Wallis test with followed by a Dunn's test.
Data were only excluded if obvious signs of poor cellular health (dendritic blebbing, spine collapse, etc.) were apparent.
Letter reSeArCH -eGFP bound to mRFP1-PLC-mRFP1 before and after BDNF or vehicle stimulation. n = 22/8 TrkB plus BDNF, 9/4 TrkB plus vehicle, and 11/4 TrkB Y816F plus BDNF (cells/experiments). d, TrkB activation (averaged over 6-10 min) for experiments in c. e, FLIM images of TrkB activation in a neuron in a mixed cortical dissociated culture before and after BDNF stimulation followed by K252a application at 30 min. f, Time course of TrkB activation measured as described in c before and after BDNF or NGF stimulation followed by K252a application. n = 8 BDNF and 4 NGF (neurons). g, TrkB activation (averaged over 10-30 min and 3-5 min following K252a application) for experiments in f. Data are mean ± s.e.m. *P < 0.05 as determined by a two-tailed unpaired samples t-test (g) or an analysis of variance (ANOVA) followed by Tukey's method to correct for multiple comparisons. (d). **P < 0.05 as determined by a two-tailed paired samples t-test. 
